IDENIX PHARMACEUTICALS, INC. (IDIX)

Healthcare: Biotechnology

Brokerage Ratings
Closing price on 12/31/2009: $2.15
Filers holding this stock on 12/31/2009: 68
Aggregate shares on 12/31/2009: 18,516,139
Aggregate shares on 09/30/2009: 18,880,513
Percent change: -1.929895%
View insider trading info since Jan. 1 2008
Quarter 1: Quarter 2:
Brokerage Ratings on this stock:
Positive:
5
Neutral:
6
Negative:
0
Brokerage Date Issued Rating Price Target
CARIS & COMPANY 11/01/2009 ABOVE AVERAGE $5.00
WEDBUSH MORGAN 10/21/2009 OUTPERFORM $5.00
JMP SECURITIES 07/21/2009 MKT PERFORM
THOMAS WEISEL 06/14/2009 OVERWEIGHT $8.00
THINKEQUITY 01/27/2009 ACCUMULATE $6.00
OPPENHEIMER 10/15/2008 PERFORM
SUSQUEHANNA FINANCIAL 04/29/2008 NEUTRAL
FRIEDMAN BILLINGS 11/08/2007 MKT PERFORM $4.00
MAXIM GROUP 06/13/2007 HOLD
BEAR STEARNS 06/12/2007 PEER PERFORM
MORGAN JOSEPH 04/15/2007 HOLD
Schedule 13d filings involving this stock
Filing Company Subject Company Date of Filing
View Amended Schedule 13D IDENIX PHARMACEUTICALS INC IDENIX PHARMACEUTICALS, INC. 05/20/2009
Non-derivative Insider Transactions
Transaction Date Owner Shares Purchased/Sold Edgar filing
09/02/2008
NOVARTIS AG
NOVARTIS PHARMA AG
 4,654 View Filing
11/19/2008
NOVARTIS AG
NOVARTIS PHARMA AG
 4,747 View Filing
02/23/2009
NOVARTIS AG
NOVARTIS PHARMA AG
 5,444 View Filing
05/29/2009
NOVARTIS AG
NOVARTIS PHARMA AG
 2,451 View Filing
08/21/2009
NOVARTIS AG
NOVARTIS PHARMA AG
 3,571 View Filing
11/24/2009
WEIDENBRUCH JOHN
 20,000 View Filing
12/10/2009
HODGSON THOMAS R
 24,613 View Filing
12/15/2009
HODGSON THOMAS R
 25,387 View Filing
02/26/2010
NOVARTIS AG
NOVARTIS PHARMA AG
 1,872 View Filing